| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/04/2007 | CN1990037A Thymosin alpha1 active fragment and polyethylene glycol derivative thereof |
| 07/04/2007 | CN1990034A Compound cantharis drop pills and its preparation method |
| 07/04/2007 | CN1990032A Composite intravenous injection emulsion of glossy ganoderma spore oil and coix seed oil and method for making same |
| 07/04/2007 | CN1990031A Crude drug for preventing tumor metastasis |
| 07/04/2007 | CN1989991A Process for preparing rhodiola root extract |
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
| 07/04/2007 | CN1989961A Use of non-steroidal sulfamate compound in the prepararion of drug for treating tumor |
| 07/04/2007 | CN1324136C SiRNA double chain for inhibiting bc 1-2 gen expression and use |
| 07/04/2007 | CN1324034C Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 07/04/2007 | CN1324032C Novel 9-nitro campotothecin crystal form and medicinal composition |
| 07/04/2007 | CN1324028C Variolin derivatives as anti-cancer agents |
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324024C Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 07/04/2007 | CN1324022C Inhibitors of tyrosine kinases |
| 07/04/2007 | CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 07/04/2007 | CN1324008C Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2007 | CN1324006C Beta-amino acid nitrile derivs. |
| 07/04/2007 | CN1324004C New phenyl-naphthalene derivatives, and preparation method and drug containing same |
| 07/04/2007 | CN1323996C Novel lignin and its preparation process and use |
| 07/04/2007 | CN1323723C Tie2 receptor mediated gene transfer system for targeted tumor gene therapy |
| 07/04/2007 | CN1323722C Positional isomers of PEG IFN alpha 2a |
| 07/04/2007 | CN1323691C Medicine for treating esophagus cancer and gastric cancer, and its preparation |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238796 Oncogenic protein for use in diagnosis, prevention and treatment of cell proliferative disorders of nervous ystem |
| 07/03/2007 | US7238778 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same |
| 07/03/2007 | US7238704 For use as inhibitors of cellular mitosis and proliferation |
| 07/03/2007 | US7238701 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders |
| 07/03/2007 | US7238700 A2B adenosine receptor antagonists |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238682 Two two hsp-binding ansamycin antibiotic moieties connected to one another by a linker that bind to the pocket of hsp90 and are effective for inducing the degradation and/or inhibition of HER-family tyrosine kinases; used for treating HER-positive cancers with reduced toxicity |
| 07/03/2007 | US7238667 Albumin fusion proteins |
| 07/03/2007 | US7238507 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 07/03/2007 | US7238379 Process for selectivity extracting bioactive components |
| 07/03/2007 | US7238367 Liposome loading with metal ions |
| 07/03/2007 | US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance |
| 07/03/2007 | US7238339 Chelate metal ions that can be detected either by their paramagnetic or radioactive properties; diagnostic and therapeutic agents |
| 07/03/2007 | CA2361987C Goodpasture antigen binding protein |
| 07/03/2007 | CA2256413C Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 07/03/2007 | CA2252465C Urea derivatives as inhibitors of impdh enzyme |
| 07/03/2007 | CA2158869C Recombinant virus, process for preparing the same and use thereof in gene therapy |
| 07/03/2007 | CA2156162C Cancer treatment |
| 06/28/2007 | WO2007073518A2 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 06/28/2007 | WO2007073303A2 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | WO2007073231A1 Agent for treating tumoral diseases, a method for the production thereof and a method for treating tumoral diseases |
| 06/28/2007 | WO2007073127A1 Anticancer agent comprising a peptide |
| 06/28/2007 | WO2007073117A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 06/28/2007 | WO2007073005A1 Regulator of methyl transfer reaction |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072965A1 Angiogenesis inhibitor and utilization of the same |
| 06/28/2007 | WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME |
| 06/28/2007 | WO2007072866A1 Anti-ilt7 antibody |
| 06/28/2007 | WO2007072800A1 Photosensitizing compound |
| 06/28/2007 | WO2007072645A1 Method of regulating cell size and/or cell cycle |
| 06/28/2007 | WO2007072504A1 Dna vaccine for cancer therapy |
| 06/28/2007 | WO2007072158A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 06/28/2007 | WO2007072041A1 Therapeutic compounds |
| 06/28/2007 | WO2007072022A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 06/28/2007 | WO2007071970A2 Combination of azd2171 and pemetrexed |
| 06/28/2007 | WO2007071961A1 Benzamide derivatives |
| 06/28/2007 | WO2007071958A2 Combination of zd6474 and pemetrexed |
| 06/28/2007 | WO2007071956A1 Novel benzamide derivatives |
| 06/28/2007 | WO2007071955A1 Chemical compounds |
| 06/28/2007 | WO2007071951A1 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
| 06/28/2007 | WO2007071777A2 Immuno-rna-constructs |
| 06/28/2007 | WO2007071648A1 Crystalline form of vinflunine ditartrate |
| 06/28/2007 | WO2007071625A2 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 06/28/2007 | WO2007071621A1 Heteroarylpyrrolopyridinones active as kinase inhibitors |
| 06/28/2007 | WO2007071603A1 Treatment of drug-resistant tumors |
| 06/28/2007 | WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 06/28/2007 | WO2007071410A1 Method for treating urinary bladder cancer |
| 06/28/2007 | WO2007071409A1 Method for treating colon cancer |
| 06/28/2007 | WO2007071348A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 06/28/2007 | WO2007071205A2 A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy |
| 06/28/2007 | WO2007071069A1 Transcription factor decoy oligodeoxynucleotides having multiple cis elements |
| 06/28/2007 | WO2007071051A1 Novel cancer-associated antigen |
| 06/28/2007 | WO2007071023A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/28/2007 | WO2007070986A1 Flavones |
| 06/28/2007 | WO2007070985A1 Tiglien-3-one derivatives |
| 06/28/2007 | WO2007070984A1 Spiroketals |
| 06/28/2007 | WO2007070981A1 Compounds having cytokine modulating properties |
| 06/28/2007 | WO2007070961A1 Mif inhibitors |
| 06/28/2007 | WO2007059154A3 Treatment of cancers with acquired resistance to kit inhibitors |
| 06/28/2007 | WO2007054573A3 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and egfr inhibitors or pyrimidine analogues |
| 06/28/2007 | WO2007048066A3 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| 06/28/2007 | WO2007048065A3 Pyrimidinones as casein kinase ii (ck2) modulators |
| 06/28/2007 | WO2007025186A3 Hydrazone agents to treat cutaneous lesions |
| 06/28/2007 | WO2007013480A3 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 06/28/2007 | WO2007002069A3 Serum biomarkers for breast cancer |
| 06/28/2007 | WO2006138427A3 Combretastatin analogs with tubulin binding activity |
| 06/28/2007 | WO2006114065A3 Use of compounds to inhibit neoplasia |
| 06/28/2007 | WO2006114064A3 Use of compounds to enhance processivity of telomerase |
| 06/28/2007 | WO2006113703A3 Carboline derivatives useful in the treatment of cancer |
| 06/28/2007 | WO2002083919A3 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070149571 Combination therapy for treating or managing acute myelocytic leukemia |
| 06/28/2007 | US20070149546 4-Anilino-quinazoline derivatives as antiproliferative agents |
| 06/28/2007 | US20070149545 Substituted indan derivatives |